Systematic characterization of gene families and functional analysis of PvRAS3 and PvRAS4 involved in rosmarinic acid biosynthesis in Prunella vulgaris
is an important material for Chinese medicines with rosmarinic acid (RA) as its index component. Based on the chromosome-level genome assembly we obtained recently, 51 RA biosynthesis-related genes were identified. Sequence feature, gene expression pattern and phylogenetic relationship analyses show...
Saved in:
Published in | Frontiers in plant science Vol. 15; p. 1374912 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
01.05.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | is an important material for Chinese medicines with rosmarinic acid (RA) as its index component. Based on the chromosome-level genome assembly we obtained recently, 51 RA biosynthesis-related genes were identified. Sequence feature, gene expression pattern and phylogenetic relationship analyses showed that 17 of them could be involved in RA biosynthesis.
enzymatic assay showed that PvRAS3 catalyzed the condensation of
-coumaroyl-CoA and caffeoyl-CoA with pHPL and DHPL. Its affinity toward
-coumaroyl-CoA was higher than caffeoyl-CoA. PvRAS4 catalyzed the condensation of
-coumaroyl-CoA with pHPL and DHPL. Its affinity toward
-coumaroyl-CoA was lower than PvRAS3. UPLC and LC-MS/MS analyses showed the existence of RA, 4-coumaroyl-3',4'-dihydroxyphenyllactic acid, 4-coumaroyl-4'-hydroxyphenyllactic acid and caffeoyl-4'-hydroxyphenyllactic acid in
. Generation and analysis of
homozygous mutants showed significant decrease of RA, 4-coumaroyl-3',4'-dihydroxyphenyllactic acid, 4-coumaroyl-4'-hydroxyphenyllactic acid and caffeoyl-4'-hydroxyphenyllactic acid and significant increase of DHPL and pHPL. It suggests that PvRAS3 is the main enzyme catalyzing the condensation of acyl donors and acceptors during RA biosynthesis. The role of PvRAS4 appears minor. The results provide significant information for quality control of
medicinal materials. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Sibongile Mafu, University of Massachusetts Amherst, United States These authors have contributed equally to this work Edited by: Naoki Kitaoka, Hokkaido University, Japan Reviewed by: Takafumi Shimizu, Research Institute of Innovative Technology for the Earth (RITE), Japan |
ISSN: | 1664-462X 1664-462X |
DOI: | 10.3389/fpls.2024.1374912 |